title: Identification of novel prognostic markers in relapsing localized resectable neuroblastoma.
abstract: Patients with localized resectable neuroblastoma (NB) generally have an excellent prognosis and can be treated by surgery alone, but approximately 10% of them develop local recurrences or metastatic progression. The known predictive risk factors are important for the identification of localized resectable NB patients at risk of relapse and/or progression, who may benefit from early and aggressive treatment. These factors, however, identify only a subset of patients at risk, and the search for novel prognostic markers is warranted. This review focuses on the recent advances in the identification of new prognostic markers. Recently we addressed the search of novel genetic prognostic markers in a selected cohort of patients with stroma-poor localized resectable NB who underwent disease relapse or progression (group 1) or complete remission (group 2). High-resolution array-comparative genomic hybridization (CGH) DNA copy-number analysis technology was used. Chromosome 1p36.22p36.32 loss and 1q22qter gain, detected almost exclusively in group 1 patients, were significantly associated with poor event-free survival (EFS). Increasing evidence points to anaplastic lymphoma kinase (ALK) as a fundamental oncogene associated with NB. The immunohistochemical analysis of sporadic NB localized resectable primary tumors (stage 1-2) showed a correlation between aberrant ALK level of expression and tumor progression and clinical outcome. Moreover, other factors that might influence the clinical behavior of these tumors will be reviewed.
authors.affiliation: Laboratory of Oncology, IRCCS G.Gaslini Hospital, Genova, Italy.
authors.forename: Federica
authors.initials: F
authors.lastname: Parodi
authors.forename: Lorena
authors.initials: L
authors.lastname: Passoni
authors.forename: Luisa
authors.initials: L
authors.lastname: Massimo
authors.forename: Roberto
authors.initials: R
authors.lastname: Luksch
authors.forename: Claudio
authors.initials: C
authors.lastname: Gambini
authors.forename: Elena
authors.initials: E
authors.lastname: Rossi
authors.forename: Orsetta
authors.initials: O
authors.lastname: Zuffardi
authors.forename: Vito
authors.initials: V
authors.lastname: Pistoia
authors.forename: Annalisa
authors.initials: A
authors.lastname: Pezzolo
mesh_terms: D015415:Biomarkers / Q000032:analysis* / Q000378:metabolism; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000473:pathology; D009447:Neuroblastoma / Q000175:diagnosis* / Q000473:pathology; D011379:Prognosis
chemical_list: D015415:Biomarkers